Denegri S, Faure H. It's plain and simple: transparency is good for science and in the public interest. Trials 2013;14:215
(doi: 10.1186/1745-6215-14-215)
In the past couple of years, there has been a growing focus on the need to make scientific output accessible to a greater number of people, especially in the field of clinical research. The public are being urged to become more well-informed and to ask their doctors about taking part in clinical trials.
All recent initiatives demonstrate that there are still a number of challenges in making current research both accessible and understandable by prospective participants. It is necessary to improve ‘signposting’, to direct the public to the information. Plain English summaries are seen as a good idea but very few people are willing to pay for improved content.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735400/
(doi: 10.1186/1745-6215-14-215)
In the past couple of years, there has been a growing focus on the need to make scientific output accessible to a greater number of people, especially in the field of clinical research. The public are being urged to become more well-informed and to ask their doctors about taking part in clinical trials.
All recent initiatives demonstrate that there are still a number of challenges in making current research both accessible and understandable by prospective participants. It is necessary to improve ‘signposting’, to direct the public to the information. Plain English summaries are seen as a good idea but very few people are willing to pay for improved content.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735400/
Comments